Physician profile
Kimberli E Carpenter
NPI 1023073046
$1,086.74
in general payments reported to CMS, 2019-2025
17 companies · $93.76 in 2025
The $93.76 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $330 · 2021: $138 · 2022: $68.76 · 2025: $93.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flowonix Medical Incorporated | $288.39 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $286.46 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $93.76 | 2025 | Caldolor |
| Collegium Pharmaceutical, INC. | $75.95 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $66.17 | 2019-2021 | |
| Medtronic USA, INC. | $48.11 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $36.95 | 2022 | |
| Redhill Biopharma INC. | $35.92 | 2021 | |
| Pfizer INC. | $28.63 | 2019-2020 | |
| Boston Scientific Corporation | $22.09 | 2020 | |
| Nalu Medical, INC. | $20.11 | 2022 | |
| Bioventus LLC | $16.39 | 2020 | |
| Depuy Synthes Sales INC. | $16.38 | 2021 | |
| Orthogenrx INC. | $16.05 | 2020 | |
| Abbott Laboratories | $12.60 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $11.70 | 2022 | |
| Zimmer Biomet Holdings, INC. | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberli Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.